Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Lonafarnib and bulevirtide, when used with pegylated interferon, reduced hepatitis delta levels in two studies.
Drugs that have a favorable effect on biomarkers may still play a role in combination therapy, however.
Acting Commissioner Ned Sharpless will return to lead the National Cancer Institute.
Selonsertib did not improve liver fibrosis more than a placebo.
Clinical trials often exclude key patient populations, including children and people living with HIV or hepatitis B or C.
Brain cancer patient begins treatment with experimental vaccine.
A speedy overview of the major scientific findings presented at the International AIDS Conference in Amsterdam (AIDS 2018)
Congress passes legislation to increase access to unapproved therapies for life-threatening diseases.
Latest version of legislation to bypass FDA oversight must now to go back to the Senate.
Controversial legislation would have allowed patients to try experimental therapies without FDA oversight.
Ideally, all patients with advanced cancers would be in clinical trials. Until then, the right to try is an option we all should have.
Right to Try bills attack the one agency tasked with verifying the safety and efficacy of medications.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.